⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VNDA News
Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit
prnewswire.com
VNDA
Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Marie-Tooth Disease Type 2S
prnewswire.com
VNDA
Revolutionizing Cancer Treatment: Global Microbiome Oncology Market Set to Surge at 40.7% CAGR, Reaching $1.94 Billion by 2031
globenewswire.com
VNDA
Insomnia Market Witnesses Robust Growth During the Forecast Period (2026-2036) with Emerging Orexin Receptor Antagonists and Melatonin Receptor Agonist | DelveInsight
prnewswire.com
JNJ
VNDA
PFE
MRK
Form 8-K
sec.gov
VNDA
Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis
prnewswire.com
VNDA
Tradipitant Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
globenewswire.com
VNDA
Oligonucleotides Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight
globenewswire.com
IONS
ALNY
NVS
BIIB
ARWR
SLN
WVE
VNDA
NSP
TCRT
AMX
CDIO
SRPT
VIR
BNTX
ARCT
GSK
PFE
Form 8-K
sec.gov
VNDA
Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results
prnewswire.com
VNDA